A detailed history of Virtu Financial LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 109,759 shares of ALT stock, worth $883,559. This represents 0.04% of its overall portfolio holdings.

Number of Shares
109,759
Holding current value
$883,559
% of portfolio
0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$5.5 - $8.1 $603,674 - $889,047
109,759 New
109,759 $674,000
Q3 2020

Dec 11, 2020

SELL
$9.93 - $33.26 $381,907 - $1.28 Million
-38,460 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$2.9 - $10.71 $67,314 - $248,600
23,212 Added 152.23%
38,460 $412,000
Q4 2019

Feb 04, 2020

SELL
$1.53 - $2.15 $23,234 - $32,649
-15,186 Reduced 49.9%
15,248 $29,000
Q3 2019

Nov 20, 2019

BUY
$1.95 - $2.66 $59,346 - $80,954
30,434 New
30,434 $59,000
Q1 2019

Apr 12, 2019

SELL
$2.54 - $4.54 $41,335 - $73,883
-16,274 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$1.72 - $7.24 $27,991 - $117,823
16,274 New
16,274 $34,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $395M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.